Repurposing Approved Drugs as Inhibitors of K<sub>v</sub>7.1 and Na<sub>v</sub>1.8 to Treat Pitt Hopkins Syndrome.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 9, p. N.PAG, doi. 10.1007/s11095-019-2671-y
- By:
- Publication type:
- Article
Works matching IS 07248741 AND DT 2019 AND VI 36 AND IP 9
Results: 13
1
2
Item Response Model Adaptation for Analyzing Data from Different Versions of Parkinson's Disease Rating Scales.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 9, p. N.PAG, doi. 10.1007/s11095-019-2668-6
- By:
- Publication type:
- Article
3
Challenging the CNS Targeting Potential of Systemically Administered Nanoemulsion Delivery Systems: a Case Study with Rapamycin-Containing Fish Oil Nanoemulsions in Mice.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 9, p. N.PAG, doi. 10.1007/s11095-019-2667-7
- By:
- Publication type:
- Article
4
Development and Characterization of a Dry Powder Formulation for Anti-Tuberculosis Drug Spectinamide 1599.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 9, p. N.PAG, doi. 10.1007/s11095-019-2666-8
- By:
- Publication type:
- Article
5
An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 9, p. N.PAG, doi. 10.1007/s11095-019-2655-y
- By:
- Publication type:
- Article
6
Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 9, p. N.PAG, doi. 10.1007/s11095-019-2665-9
- By:
- Publication type:
- Article
7
Recent Treatment Advances and the Role of Nanotechnology, Combination Products, and Immunotherapy in Changing the Therapeutic Landscape of Acute Myeloid Leukemia.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 9, p. N.PAG, doi. 10.1007/s11095-019-2654-z
- By:
- Publication type:
- Article
8
Generation, Characterization, and Quantitative Bioanalysis of Drug/Anti-drug Antibody Immune Complexes to Facilitate Dedicated In Vivo Studies.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 9, p. N.PAG, doi. 10.1007/s11095-019-2661-0
- By:
- Publication type:
- Article
9
Model-based analysis of treatment effects of paclitaxel microspheres in a microscopic peritoneal carcinomatosis model in mice.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 9, p. N.PAG, doi. 10.1007/s11095-019-2660-1
- By:
- Publication type:
- Article
10
Correction to: Impact of Buffer, Protein Concentration and Sucrose Addition on the Aggregation and Particle Formation during Freezing and Thawing.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
11
Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 9, p. N.PAG, doi. 10.1007/s11095-019-2662-z
- By:
- Publication type:
- Article
12
Utility of High Resolution NMR Methods to Probe the Impact of Chemical Modifications on Higher Order Structure of Monoclonal Antibodies in Relation to Antigen Binding.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 9, p. N.PAG, doi. 10.1007/s11095-019-2652-1
- By:
- Publication type:
- Article
13
High Pressure Nebulization (PIPAC) Versus Injection for the Intraperitoneal Administration of mRNA Complexes.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 9, p. N.PAG, doi. 10.1007/s11095-019-2646-z
- By:
- Publication type:
- Article